Back to search

Article

Six years of clinical herpes simplex virus genotypic acyclovir resistance testing confirms common resistance mechanisms and identifies novel mutations

2026-06-27

Abstract excerpt

<h4>ABSTRACT</h4> Identification of acyclovir-resistant herpes simplex virus (HSV) infections is critical for directing appropriate antiviral therapy, particularly for immunocompromised patients where resistance rates can reach 30%. In 2020, the University of Washington Clinical Virology Laboratory launched the first clinical genotypic HSV drug resistance test in the United States. While genotypic testing offers...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6ef17b4e-9f70-599f-bd4d-ff452477b160
DOI
10.64898/2026.06.25.734554
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Six years of clinical herpes simplex virus genotypic acyclovir resistance testing confirms common resistance mechanisms and identifies novel mutationsDOI 10.64898/2026.06.25.734554
Select a neighboring publication to make it the new centre.